Get the Stockscreener App
1.48
4.23%
0.06
Cyclerion Therapeutics Inc stock is traded at $1.48, with a volume of 42,893.
It is up +4.23% in the last 24 hours and down -31.48% over the past month.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$1.42
Open:
$1.41
24h Volume:
42,893
Relative Volume:
0.07
Market Cap:
$5.81M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-0.6916
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
+8.82%
1M Performance:
-31.48%
6M Performance:
-51.79%
1Y Performance:
+4.23%
1-Day Range:
$1.41
$1.49
1-Week Range:
$1.33
$1.50
52-Week Range:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Name
Cyclerion Therapeutics Inc
Sector
Industry
Phone
617-621-7722
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.48 | 5.40M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-21 | Initiated | Truist | Buy |
| Sep-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-03-19 | Initiated | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Stock (CYCN) Latest News
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & High Return Wealth Plans - earlytimes.in
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings seasonWeekly Stock Report & Short-Term Trading Opportunity Alerts - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Cyclerion Therapeutics, Inc. Quarterly Earnings Report | CYCN SEC FilingForm 10-Q - Stock Titan
Short interest data insights for Cyclerion Therapeutics Inc.Weekly Trend Report & Fast Moving Market Watchlists - newser.com
Prepare Yourself for Liftoff: Cyclerion Therapeutics Inc (CYCN) - Setenews
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics - Yahoo Finance
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network - Benzinga
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsForecast Cut & Daily Technical Forecast Reports - newser.com
Why Cyclerion Therapeutics Inc. stock is a value investor pickTrade Analysis Report & Low Risk Profit Maximizing Plans - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc. stock recession proofQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
Will Cyclerion Therapeutics Inc. stock recover faster than marketMarket Risk Summary & Low Volatility Stock Suggestions - Fundação Cultural do Pará
Cyclerion Therapeutics Inc Stock (CYCN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):